Formuepleje A/S’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.2M | Buy |
23,786
+3,263
| +16% | +$1.21M | 0.72% | 24 |
|
|
2026
Q1 | $6.01M | Buy |
+20,523
| New | +$6.75M | 0.54% | 33 |
|
|
2025
Q3 | – | Sell |
-74,830
| Closed | -$32.5M | – | 54 |
|
|
2025
Q2 | $32.5M | Hold |
74,830
| – | – | 1.86% | 21 |
|
|
2025
Q1 | $32.5M | Sell |
74,830
-15,538
| -17% | -$6.24M | 1.86% | 21 |
|
|
2024
Q4 | $33.3M | Buy |
90,368
+32,078
| +55% | +$13.4M | 1.8% | 20 |
|
|
2024
Q3 | $30.3M | Buy |
58,290
+525
| +0.9% | +$280K | 1.55% | 27 |
|
|
2024
Q2 | $31.3M | Buy |
57,765
+29,921
| +107% | +$15.8M | 1.73% | 19 |
|
|
2024
Q1 | $14.4M | Buy |
27,844
+14,878
| +115% | +$7.4M | 0.82% | 39 |
|
|
2023
Q4 | $6.11M | Buy |
+12,966
| New | +$6M | 0.43% | 70 |
|
|
2022
Q4 | – | Sell |
-66,661
| Closed | -$30.3M | – | 90 |
|
|
2022
Q3 | $30.3M | Sell |
66,661
-67,507
| -50% | -$32.3M | 2.46% | 9 |
|
|
2022
Q2 | $64.7M | Sell |
134,168
-34,796
| -21% | -$17.2M | 3.97% | 5 |
|
|
2022
Q1 | $84.9M | Sell |
168,964
-171,070
| -50% | -$78.2M | 3.68% | 8 |
|
|
2021
Q4 | $158M | Sell |
340,034
-139,309
| -29% | -$58.6M | 6% | 2 |
|
|
2021
Q3 | $179M | Buy |
479,343
+87,014
| +22% | +$33.1M | 7.15% | 2 |
|
|
2021
Q2 | $150M | Sell |
392,329
-150,317
| -28% | -$57.4M | 5.79% | 3 |
|
|
2021
Q1 | $195M | Buy |
542,646
+48,863
| +10% | +$15.7M | 7.42% | 2 |
|
|
2020
Q4 | $159M | Sell |
493,783
-174,638
| -26% | -$53.6M | 6.72% | 3 |
|
|
2020
Q3 | $180M | Buy |
668,421
+147,193
| +28% | +$39.6M | 7.83% | 2 |
|
|
2020
Q2 | $137M | Buy |
521,228
+58,986
| +13% | +$15.7M | 6.9% | 2 |
|
|
2020
Q1 | $105M | Buy |
462,242
+101,168
| +28% | +$27.6M | 6.97% | 2 |
|
|
2019
Q4 | $109M | Buy |
361,074
+3,025
| +0.8% | +$832K | 7.04% | 3 |
|
|
2019
Q3 | $86M | Buy |
358,049
+13,455
| +4% | +$3.69M | 6.32% | 4 |
|
|
2019
Q2 | $97.2M | Buy |
344,594
+30,323
| +10% | +$8.28M | 7.56% | 3 |
|
|
2019
Q1 | $90.2M | Sell |
314,271
-10,085
| -3% | -$2.92M | 8.03% | 3 |
|
|
2018
Q4 | $85.2M | Sell |
324,356
-41,765
| -11% | -$11.5M | 9.36% | 2 |
|
|
2018
Q3 | $100M | Sell |
366,121
-21
| -0% | -$5.45K | 9.63% | 1 |
|
|
2018
Q2 | $87.2M | Buy |
366,142
+39,000
| +12% | +$9.03M | 9.21% | 1 |
|
|
2018
Q1 | $71.9M | Sell |
327,142
-49,200
| -13% | -$11.6M | 8.46% | 1 |
|
|
2017
Q4 | $84.7M | Buy |
376,342
+2,994
| +0.8% | +$638K | 8.67% | 1 |
|
|
2017
Q3 | $70.9M | Buy |
373,348
+2,400
| +0.6% | +$457K | 7.79% | 1 |
|
|
2017
Q2 | $69.8M | Buy |
370,948
+9,100
| +3% | +$1.64M | 7.27% | 2 |
|
|
2017
Q1 | $59.8M | Buy |
361,848
+75,600
| +26% | +$12M | 7.15% | 3 |
|
|
2016
Q4 | $41.2M | Buy |
286,248
+35,000
| +14% | +$4.69M | 5.41% | 4 |
|
|
2016
Q3 | $31.5M | Buy |
251,248
+176,500
| +236% | +$22.8M | 4.25% | 8 |
|
|
2016
Q2 | $9.82M | Sell |
74,748
-5,500
| -7% | -$753K | 1.34% | 27 |
|
|
2016
Q1 | $11.2M | Sell |
80,248
-9,260
| -10% | -$1.24M | 1.4% | 26 |
|
|
2015
Q4 | $12.5M | Sell |
89,508
-1,190
| -1% | -$164K | 1.42% | 28 |
|
|
2015
Q3 | $12.7M | Buy |
90,698
+2,170
| +2% | +$326K | 1.55% | 22 |
|
|
2015
Q2 | $14.5M | Sell |
88,528
-11,140
| -11% | -$1.78M | 1.71% | 20 |
|
|
2015
Q1 | $15.4M | Sell |
99,668
-11,470
| -10% | -$1.63M | 1.82% | 21 |
|
|
2014
Q4 | $14M | Sell |
111,138
-191,120
| -63% | -$23.6M | 1.78% | 19 |
|
|
2014
Q3 | $36.2M | Sell |
302,258
-108,310
| -26% | -$12.4M | 4.74% | 7 |
|
|
2014
Q2 | $44.2M | Buy |
410,568
+244,949
| +148% | +$25.2M | 4.43% | 9 |
|
|
2014
Q1 | $16.5M | Buy |
+165,619
| New | +$15M | 1.94% | 19 |
|
Other funds holding ELV
Formuepleje A/S's ELV Position: Q2 2026 in Review
Formuepleje A/S increased its Elevance Health (ELV) stake by 16% in Q2 2026, buying an estimated $1.21M and bringing the position to 23,786 shares worth $9.2M. The position accounts for 0.72% of the portfolio, ranked #24.
Formuepleje A/S first reported a position in ELV in Q1 2014 and has held it in 44 quarters since. The position peaked at $195M in Q1 2021. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Formuepleje A/S held 23,786 shares of Elevance Health worth $9.2M as of Q2 2026.
- Formuepleje A/S bought 3,263 Elevance Health shares in Q2 2026, an estimated $1.21M.
- Elevance Health made up 0.72% of Formuepleje A/S's portfolio in Q2 2026, its #24 holding.
- Formuepleje A/S first reported a position in Elevance Health in Q1 2014 and has held it in 44 quarters since.
- Formuepleje A/S's Elevance Health position peaked at $195M in Q1 2021.
- 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Formuepleje A/S's 13F filing for Q2 2026, filed 27 Aug 2026.